PD-1 antibody

PD-1 inhibitor

Drug timelines are a Plus or Pro feature.

80 regulatory and trial events tracked for PD-1 antibody, covering 2017-06-09 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE） [Phase 2]